Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...

A priority review in Stargardt disease, two pivotal-trial milestones, an emerging bispecific for wet AMD, and new diagnostic ...

Bevacizumab is a cornerstone retina drug that has been used off-label for decades. Where the FDA-cleared branded version fits ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

Researchers at the University of Oklahoma are advancing the fight against inherited retinal diseases (IRDs) with new genetic research that aims to improve diagnoses and lay the groundwork for future ...

Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...

Walter and Eliza Hall Institute of Medical Research in Victoria, Australia led one of the largest eye studies in the world that used AI to analyse eye images of over 50,000 people to better understand ...

Ocugen (OCGN) is a clinical-stage biotech focused on modifier gene therapies for inherited retinal diseases, with key catalysts expected by 2026. OCGN's pipeline includes OCU400 (RP/LCA), OCU410ST ...

The status of the choriocapillaris may be a valuable factor when monitoring the macular microvasculature in prediabetes and ...

Researchers have developed a new way to study CLN3-Batten disease, a rare inherited condition that causes early vision loss ...

Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today ...

World Retina Day is all about shining a light on the importance of eye health, specifically the retina, that tiny but mighty part at the back of your eye that makes clear vision possible. Without it, ...